Clinical Trial Update: Allogenic Cord Blood Transfusion in Patients With Autism [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial investigating allogenic cord blood transfusion for Autism Spectrum Disorder; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Cord blood transplantation

Snippet

Sponsor: State-Financed Health Facility "Samara Regional Medical Center Dinasty" | Conditions: Autism Spectrum Disorder, Autism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-19